DiscoverThe Rounds TableEpisode 131 - Zoledronate for Fracture Prevention and Semaglutide in Type 1 Diabetes and Obesity
Episode 131 - Zoledronate for Fracture Prevention and Semaglutide in Type 1 Diabetes and Obesity

Episode 131 - Zoledronate for Fracture Prevention and Semaglutide in Type 1 Diabetes and Obesity

Update: 2025-08-21
Share

Description

Send us a text

Welcome back Rounds Table Listeners! We are back today with a Classic Rapid Fire episode. This week, Drs. Mike and John Fralick discuss two recent papers: the effects of infrequent zoledronate administration on vertebral fracture prevention in early postmenopausal women, and the efficacy and safety of semaglutide in adults with type 1 diabetes and obesity. Two papers, here we go!

  1. Fracture Prevention with Infrequent Zoledronate in Women 50 to 60 Years of Age (0:0010:24 )
  2. Semaglutide in Adults with Type 1 Diabetes and Obesity (10:2517:48 )

And for the Good Stuff (17:4919:46 ):

Thank you to our sponsor, FIGS scrubs. Rounds Table listeners can save 20% on their next purchase with code FIGSCA at https://www.wearfigs.com/.

Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 131 - Zoledronate for Fracture Prevention and Semaglutide in Type 1 Diabetes and Obesity

Episode 131 - Zoledronate for Fracture Prevention and Semaglutide in Type 1 Diabetes and Obesity